Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Anti-Cancer Drugs
|
April 1, 1994
Didemnin B in metastatic malignant melanoma: a phase II trial of the Southwest Oncology Group
V K Sondak, K J Kopecky, P Y Liu, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
January 1, 1989
Photodynamic therapy for esophageal tumors
J S McCaughan, T A Nims, J T Guy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Evaluation of topotecan in resistant and relapsing multiple myeloma: a Southwest Oncology Group study
E H Kraut, J J Crowley, J L Wade, et al.
Cancer
|
February 1, 1995
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study
W S Dalton, J J Crowley, S S Salmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1986
Chemotherapy of drug-resistant ovarian cancer: a Southwest Oncology Group Study
L R Laufman, J B Green, D S Alberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1993
A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer
L R Laufman, R M Bukowski, M A Collier, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1988
Clinical experience with CF-FUra
L R Laufman, W D Brenckman, K A Stydnicki, et al.
Cancer
|
March 15, 1989
Clinical experience with leucovorin and 5-fluorouracil
L R Laufman, W D Brenckman, K A Stydnicki, et al.
Cancer
|
September 26, 1997
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group
P N Grozea, J J Crowley, V A Canfield, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 16, 1998
Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229)
C R Thomas, D J Giroux, K J Stelzer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Anti-Cancer Drugs
|
April 1, 1994
Didemnin B in metastatic malignant melanoma: a phase II trial of the Southwest Oncology Group
V K Sondak, K J Kopecky, P Y Liu, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
January 1, 1989
Photodynamic therapy for esophageal tumors
J S McCaughan, T A Nims, J T Guy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Evaluation of topotecan in resistant and relapsing multiple myeloma: a Southwest Oncology Group study
E H Kraut, J J Crowley, J L Wade, et al.
Cancer
|
February 1, 1995
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study
W S Dalton, J J Crowley, S S Salmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1986
Chemotherapy of drug-resistant ovarian cancer: a Southwest Oncology Group Study
L R Laufman, J B Green, D S Alberts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1993
A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer
L R Laufman, R M Bukowski, M A Collier, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1988
Clinical experience with CF-FUra
L R Laufman, W D Brenckman, K A Stydnicki, et al.
Cancer
|
March 15, 1989
Clinical experience with leucovorin and 5-fluorouracil
L R Laufman, W D Brenckman, K A Stydnicki, et al.
Cancer
|
September 26, 1997
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group
P N Grozea, J J Crowley, V A Canfield, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 16, 1998
Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229)
C R Thomas, D J Giroux, K J Stelzer, et al.
Page
of 3